Center for Esophageal Diseases and Swallowing, and Center for Gastrointestinal Biology and Disease, Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina School of Medicine, CB #7080, Rm 4140 Bioinformatics Bldg, 130 Mason Farm Rd, Chapel Hill, NC, 27599-7080, USA.
Division of Pediatric Gastroenterology, Department of Pediatrics, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC, 27157, USA.
Dig Dis Sci. 2018 Sep;63(9):2381-2388. doi: 10.1007/s10620-018-4931-9. Epub 2018 Jan 29.
Few studies have examined combined or alternating treatment algorithms in eosinophilic esophagitis.
We conducted a retrospective cohort study to ascertain the efficacy and adherence to a combined and alternating treatment approach with topical corticosteroids and 2-food elimination diet for pediatric EoE.
Patients were prescribed a 2-food elimination diet (milk and soy) and topical corticosteroid (fluticasone or oral viscous budesonide) for 3 months, after which the steroid was discontinued and 2-food elimination diet continued for 3 months. An EGD was performed at baseline, 3 and 6 months. Clinical, endoscopic, and histologic data were extracted from electronic medical records. Nonparametric tests assessed adherence and outcomes.
Twenty-nine eosinophilic esophagitis cases were included (mean age 11.5 years, 61% male). Complete adherence to combined therapy and 2-food elimination diet alone was 75 and 79%, respectively. Median eosinophil counts decreased from 51 to 2 eosinophils/hpf (p < 0.001) after combined treatment and rebounded to 31 (p = 0.07) after 2FED alone. Dysphagia improved after both the combined and 2-food elimination diet alone treatment approaches (52 vs. 11% and 10%; p = 0.001, 0.005). Nonsignificant improvements in endoscopic findings were documented across the length of follow-up.
An initial combined treatment approach resulted in significant improvements in symptoms and histologic findings. While symptomatic improvements continued with 2-food elimination diet alone, the histologic improvement was not maintained. While loss to follow-up may obscure the efficacy of 2-food elimination diet alone, a combined/alternating treatment approach merits assessment in a larger prospective study.
很少有研究探讨过嗜酸性粒细胞性食管炎的联合或交替治疗方案。
我们进行了一项回顾性队列研究,以确定联合和交替使用局部皮质类固醇和 2 种食物排除饮食治疗儿科嗜酸性粒细胞性食管炎的疗效和依从性。
患者接受 2 种食物排除饮食(牛奶和大豆)和局部皮质类固醇(氟替卡松或口服粘性布地奈德)治疗 3 个月,之后停用类固醇,继续 2 种食物排除饮食 3 个月。在基线、3 个月和 6 个月时进行食管胃十二指肠镜检查。从电子病历中提取临床、内镜和组织学数据。非参数检验评估了依从性和结果。
纳入了 29 例嗜酸性粒细胞性食管炎病例(平均年龄 11.5 岁,61%为男性)。联合治疗和单独 2 种食物排除饮食的完全依从率分别为 75%和 79%。联合治疗后嗜酸性粒细胞计数中位数从 51 降至 2 个/高倍视野(p < 0.001),单独 2 种食物排除饮食后反弹至 31 个(p = 0.07)。联合治疗和单独 2 种食物排除饮食治疗后吞咽困难均有改善(52%比 11%和 10%;p = 0.001,0.005)。在整个随访期间,内镜检查结果均有轻微改善。
初始联合治疗方法可显著改善症状和组织学发现。虽然单独 2 种食物排除饮食治疗后症状仍有改善,但组织学改善未能维持。虽然随访失访可能会影响单独 2 种食物排除饮食的疗效,但联合/交替治疗方法值得在更大的前瞻性研究中进行评估。